Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936

Diabetologia. 2006 Nov;49(11):2805-6. doi: 10.1007/s00125-006-0323-3. Epub 2006 Jun 21.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged, 80 and over
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin-Secreting Cells / physiology*
  • Metformin / therapeutic use
  • Regeneration
  • Sulfonylurea Compounds / therapeutic use

Substances

  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Metformin